Related Experiment Video
Updated: Jan 31, 2026

05:30
Controlled Cortical Impact Model for Traumatic Brain Injury
Published on: August 5, 2014
29.7K
How to Translate Time: The Temporal Aspects of Rodent and Human Pathobiological Processes in Traumatic Brain Injury
Denes V Agoston1, Robert Vink2, Adel Helmy3
11 Department of Anatomy, Physiology and Genetics, Uniformed Services University, Bethesda, Maryland.
Journal of Neurotrauma
|January 11, 2019
Summary
Rodent and human traumatic brain injury (TBI) healing occur on different timelines, hindering drug development. Understanding these species-specific pathological processes is key to improving TBI treatments.
Area of Science:
- Neuroscience
- Translational Medicine
- Pharmacology
Background:
- Traumatic brain injury (TBI) involves complex, time-dependent biological responses.
- Numerous experimental TBI pharmacotherapies have failed in clinical trials, suggesting a translational gap.
- Differences in biological and pathological process timescales between rodents and humans may contribute to these failures.
Purpose of the Study:
- To compare the temporal dynamics of TBI-induced pathologies in rodent and human models.
- To identify factors contributing to the failure of translating experimental TBI treatments to clinical practice.
- To propose strategies for improving the translation of TBI research.
Main Methods:
- Comparative analysis of published data on rodent and human TBI models.
- Examination of time scales for TBI-induced changes in cerebral glucose metabolism, inflammation, axonal integrity, and water homeostasis.
- Review of limitations in current TBI research methodologies, including outcome measures and study frequency.
Main Results:
- TBI-induced pathological trajectories differ significantly between rodent and human models.
- No universal conversion rate exists between rodent and human pathophysiological processes.
- Inflammatory processes show a relatively shorter timescale in rodents compared to humans.
Conclusions:
- Species-specific differences in the timing of TBI pathologies present a major translational challenge.
- Current research methodologies and outcome measures may not adequately capture human-relevant disease progression.
- Recommendations include using clinically relevant outcome measures (e.g., in vivo imaging, proteomics) and collecting longitudinal data at higher frequencies to bridge the translational gap in TBI research.
Related Concept Videos
Translation
156.3K
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
156.3K
Translation
17.8K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
Translation Produces the Building Blocks of Life
Proteins are...
17.8K
Initiation of Translation
39.0K
Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
39.0K
Termination of Translation
27.7K
The large ribosomal subunit has several important structures essential to translation. These include the peptidyl transferase center (PTC) - which is the site where the peptide bond is formed - and a large, internal, water-filled tube through which the nascent polypeptide moves. This latter structure is called the Peptide Exit Tunnel, and it begins at the PTC and spans the body of the large ribosomal subunit. During translation, as the nascent polypeptide chain is synthesized, it passes through...
27.7K
Termination of Translation
6.8K
6.8K
Improving Translational Accuracy
14.9K
Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
14.9K

